Kheiron Medical Technologies Limited news
InHealth, who provide services for North and East Devon NHS Breast Screening, has entered into the research agreement to work with Kheiron Medical Technologies as part of the AI in Health & Care Award. This partnership marks another significant step in the journey to build an evidence base to demonstrate the effectiveness and safety of artificial intelligence in NHS breast cancer screening. InHealth joins two other part
Kheiron Medical Technologies today announced the hire of Dr. Ben Glocker for the position of Head of Machine Learning Research. In his role, Glocker will lead Kheiron’s work to develop AI solutions that are designed to give patients a better fighting chance against cancer. He will also support Kheiron’s w
As many as 3.9 million women in the U.S. missed their routine mammograms due to the COVID-19 pandemic,* creating a significant backlog of women to be scheduled as breast screening clinics have re-opened with reduced capacity and increased COVID-19 safety protocols. Kheiron Medical Technologies, an award-winning applied science company based in the United Kingdom, has launched RSViP™, a new artificial intelligence-enabled tool that helps breast screening programs optimize scheduling for
Kheiron Medical Technologies today announced the appointment of Dr. Wendy DeMartini, Dr. Elizabeth Morris, and Dr. Amy Patel to its US Breast Medical Advisory Board. These appointments reinforce Kheiron’s focus on bringing its artificial intelligence solutions to the US market to help radiologists detect breast cancer earlier. Kheiron is committed to assembling an inclusive advisory board that shares its mission for creating equitable access to breast cancer screening, including a
Kheiron Medical Technologies has been named to Fast Company’s prestigious annual list of the World’s Most Innovative Companies for 2022. Kheiron has pioneered the development and deployment of artificial intelligence solutions to help radiologists detect breast cancer earlier, and the company is currently leverag